NextPlat (NXPL) Change in Receivables (2015 - 2026)
NextPlat's (NXPL) quarterly Change in Receivables came in at $1.0 million in Q2 2026, up 131.78% year-over-year from $448263.3 in Q2 2025, and down 19.33% quarter-over-quarter from $1.3 million in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Change in Receivables (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Change in Receivables for 12 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables rose 131.78% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $4.3 million, a 156.31% increase from a year earlier, with the FY2025 full-year figure at -$383000.0, up 91.93% from the prior year.
- Change in Receivables was $1.0 million for Q2 2026 at NextPlat, down from $1.3 million in the prior quarter.
- Over five years, Change in Receivables peaked at $4.2 million in Q1 2024 and troughed at -$3.7 million in Q2 2024.
- A 5-year average of $37888.9 and a median of -$2460.5 in 2022 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 1461.95% in 2022 and plunged 913.08% in 2024, its largest moves.
- Over 5 years, Change in Receivables stood at -$305258.0 in 2022, then sank by 46.76% to -$448000.0 in 2023, then slumped by 277.23% to -$1.7 million in 2024, then jumped by 76.57% to -$396000.0 in 2025, then surged by 362.37% to $1.0 million in 2026.
- The last three Change in Receivables figures came in at $1.0 million (Q2 2026), $1.3 million (Q1 2026), and -$396000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 91.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 126.50 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 169.78 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 70.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 19.08 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.24 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -2.98 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 1.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | -396,000.00 |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | -3.27 Mn |
| Mar 31, 2025 | 941,000.00 |
| Dec 31, 2024 | -1.69 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.72 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Dec 31, 2023 | -448,000.00 |
| Sep 30, 2023 | 3.69 Mn |
| Jun 30, 2023 | -367,000.00 |
| Mar 31, 2023 | 572,000.00 |
| Dec 31, 2022 | -305,258.00 |
| Sep 30, 2022 | 344,179.00 |
| Jun 30, 2022 | -75,228.00 |
| Mar 31, 2022 | 70,307.00 |
| Dec 31, 2021 | 39,997.00 |
| Sep 30, 2021 | -25,271.00 |